Skip to main content

Advertisement

SpringerLink
Log in

Canadian recommendations for the management of spondyloarthritis address many different levels of patient care

  • Guidelines Summary
  • Published:

From Nature Clinical Practice Rheumatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zochling J et al. (2006) The process of producing recommendations for rheumatic diseases: what is evidence? Ann Rheum Dis 65: 979

    Article  CAS  Google Scholar 

  2. Zochling J et al. (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65: 442–452

    Article  CAS  Google Scholar 

  3. Maksymowych WP et al. (2007) The Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder project. J Rheumatol 34: 2273–2284

    PubMed  Google Scholar 

  4. Braun J et al. (2006) First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 65: 316–320

    Article  CAS  Google Scholar 

  5. Salvarani C et al. (2006) Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis. Clin Exp Rheumatol 24: 70–78

    CAS  PubMed  Google Scholar 

  6. van der Linden S et al. (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27: 361–368

    Article  CAS  Google Scholar 

  7. Zochling J et al. (2005) The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology (Oxford) 44: 1483–1491

    Article  CAS  Google Scholar 

  8. Dougados M et al. (2004) EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis 63: 1172–1176

    Article  CAS  Google Scholar 

  9. Zochling J et al.: Development of a core set of domains for data collection in cohorts of AS patients receiving anti-TNFα therapy. J Rheumatol, in press

  10. Daniels N et al. (2003) An ethical template for pharmacy benefits. Health Aff (Millwood) 22: 125–137

    Article  Google Scholar 

  11. American Medical Association Council on Ethical and Judicial Affairs (2003) Cost containment involving prescription drugs in health plans. In Code of Medical Ethics 2003–2004: Current Opinions with Annotations. Chicago, IL: American Medical Association

Download references

Author information

Author notes

  1. Rheumazentrum Ruhrgebiet, Landgrafenstr. 15, 44652 Herne, Germany j.braun@rheumazentrum-ruhrgebiet.de

Authors and Affiliations

  1. J Braun is the Medical Director of the Rheumazentrum Ruhrgebiet in Herne, Germany.,

    Jürgen Braun

Authors
  1. Jürgen Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Braun, J. Canadian recommendations for the management of spondyloarthritis address many different levels of patient care. Nat Rev Rheumatol 4, 234–235 (2008). https://doi.org/10.1038/ncprheum0766

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0766

  • Springer Nature Limited

Search

Navigation